SEC Form 4 · accession 0001179110-16-023406
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Weiland
Director
Period of report
Apr 26, 2016
Accepted (ET)
Apr 28, 2016 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.81 | Apr 26, 2016 | A | 18,000 | A | — | Apr 25, 2026 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The shares subject to the option are early exercisable. The option vests in 12 equal monthly installments with the vesting start date of April 1, 2016.